Total Payments
$1,061
2024 Payments
$315.36
Companies
13
Transactions
60
Medicare Patients
764
Medicare Billing
$84,930
Payment Breakdown by Category
Food & Beverage$1,061 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,061 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $501.82 | 36 | $0 (2024) |
| Melinta Therapeutics, Inc. | $113.19 | 6 | $0 (2019) |
| Gilead Sciences, Inc. | $88.95 | 3 | $0 (2023) |
| Eisai Inc. | $77.06 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $74.58 | 3 | $0 (2024) |
| ABBVIE INC. | $43.37 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $35.05 | 1 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $26.70 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $25.09 | 1 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $21.53 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $315.36 | 16 | ViiV Healthcare Company ($134.63) |
| 2023 | $282.70 | 19 | ViiV Healthcare Company ($222.60) |
| 2022 | $293.12 | 16 | ViiV Healthcare Company ($144.59) |
| 2021 | $39.67 | 2 | Vifor Pharma, Inc. ($19.93) |
| 2019 | $38.18 | 2 | Melinta Therapeutics, Inc. ($38.18) |
| 2018 | $75.01 | 4 | Melinta Therapeutics, Inc. ($75.01) |
| 2017 | $17.11 | 1 | PFIZER INC. ($17.11) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: HIV | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/28/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: HIV | ||||||
| 10/04/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: HIV | ||||||
| 09/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Neuropsychiatry | ||||||
| 08/26/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: HIV | ||||||
| 08/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: HIV | ||||||
| 06/21/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: HIV | ||||||
| 05/30/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Neurology | ||||||
| 05/25/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: HIV | ||||||
| 05/24/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: HIV | ||||||
| 05/02/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: HIV | ||||||
| 04/05/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $20.82 | General |
| 03/28/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Neurology | ||||||
| 01/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Neurology | ||||||
| 12/06/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: HIV | ||||||
| 11/23/2023 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: HIV | ||||||
| 10/26/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.04 | General |
| 10/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.06 | General |
| 09/28/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: HIV | ||||||
| 08/29/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $0.34 | General |
| Category: HIV | ||||||
| 08/28/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: HIV | ||||||
| 08/11/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: HIV | ||||||
| 07/28/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 237 | 357 | $70,455 | $23,206 |
| 2022 | 6 | 240 | 371 | $76,705 | $25,178 |
| 2021 | 5 | 181 | 308 | $68,995 | $23,447 |
| 2020 | 3 | 106 | 212 | $39,980 | $13,099 |
Total Patients
764
Total Services
1,248
Medicare Billing
$84,930
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 47 | 103 | $23,175 | $7,576 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 45 | 76 | $11,900 | $3,882 | 32.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 50 | 51 | $12,495 | $3,853 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 25 | $7,375 | $2,165 | 29.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 42 | $3,780 | $1,842 | 48.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 20 | $3,400 | $1,445 | 42.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 18 | 18 | $3,600 | $1,390 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 22 | $4,730 | $1,054 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 56 | 146 | $32,990 | $10,750 | 32.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 45 | 46 | $11,270 | $4,068 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 34 | $10,030 | $2,769 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 38 | 52 | $8,480 | $2,758 | 32.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 31 | $5,270 | $2,050 | 38.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 31 | 36 | $3,240 | $1,243 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 11 | 11 | $2,200 | $805.98 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 15 | $3,225 | $733.32 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 58 | 154 | $35,795 | $12,442 | 34.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 57 | $15,415 | $4,291 | 27.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 27 | 27 | $6,615 | $2,640 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 23 | 28 | $4,870 | $1,671 | 34.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 11 | 11 | $2,200 | $889.90 | 40.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $2,300 | $796.25 | 34.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 20 | $1,800 | $717.20 | 39.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 93 | $19,965 | $6,248 | 31.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 36 | 87 | $16,260 | $5,294 | 32.6% |
About Dr. Leonard Berkowitz, MD
Dr. Leonard Berkowitz, MD is a Infectious Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265534564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonard Berkowitz, MD has received a total of $1,061 in payments from pharmaceutical and medical device companies, with $315.36 received in 2024. These payments were reported across 60 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,061).
As a Medicare-enrolled provider, Berkowitz has provided services to 764 Medicare beneficiaries, totaling 1,248 services with total Medicare billing of $84,930. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Brooklyn, NY
- Active Since 09/05/2006
- Last Updated 08/07/2013
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265534564
Products in Payments
- APRETUDE (Biological) $407.46
- Leqembi (Drug) $77.06
- Baxdela (Drug) $75.01
- RUKOBIA (Drug) $41.78
- Vabomere (Drug) $38.18
- SYMTUZA (Drug) $35.05
- PIFELTRO (Drug) $34.62
- DOVATO (Drug) $28.09
- INGREZZA (Drug) $26.70
- SHINGRIX (Biological) $25.09
- CABENUVA (Biological) $24.49
- UBRELVY (Drug) $23.63
- ACTHAR (Biological) $21.53
- Veltassa (Drug) $19.93
- SYNTHROID (Drug) $19.74
- PNEUMOVAX 23 (Biological) $19.14
- CHANTIX (Drug) $17.11
- NUZYRA (Drug) $16.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Brooklyn
Andre Brutus
Infectious Disease — Payments: $379,075
Infectious Disease $379,075
Dr. Joseph Paul, M.d, M.D
Infectious Disease — Payments: $294,392
Infectious Disease $294,392
Marcus Sandling
Infectious Disease — Payments: $69,398
Infectious Disease $69,398
Dr. Jessica Yager, M.d, M.D
Infectious Disease — Payments: $46,298
Infectious Disease $46,298
Yusuf Afacan, M.d, M.D
Infectious Disease — Payments: $27,239
Infectious Disease $27,239
Dr. Jacquelyn Lahoud, M.d, M.D
Infectious Disease — Payments: $9,095
Infectious Disease $9,095